We are live on ! Find out more
NRS

Neville Rodie & Shaw Portfolio holdings

AUM $1.55B
1-Year Est. Return 46.95%
This Fund
S&P 500
This Quarter Est. Return
+14.11%
1 Year Est. Return
+46.95%
3 Year Est. Return
+114.59%
5 Year Est. Return
+149.24%
10 Year Est. Return
+498%
AUM
$944M
AUM Growth
+$119M
Cap. Flow
+$5.3M
Cap. Flow %
0.56%
Top 10 Hldgs %
30.12%
Holding
256
New
19
Increased
59
Reduced
92
Closed
3

Top Buys

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$5.03M
2
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$2.6M
3
WAB icon
Wabtec
WAB
+$2.09M
4
MPC icon
Marathon Petroleum
MPC
+$1.55M
5
BA icon
Boeing
BA
+$1.28M

Top Sells

Rank Stock Value
1
JPM icon
JPMorgan Chase
JPM
+$2.28M
2
BRK.A icon
Berkshire Hathaway Class A
BRK.A
+$2.12M
3
WFC icon
Wells Fargo
WFC
+$1.43M
4
ABBV icon
AbbVie
ABBV
+$917K
5
FDX icon
FedEx
FDX
+$843K

Sector Composition

Rank Sector Weight
1 Healthcare 19.73%
2 Industrials 14.53%
3 Technology 14.16%
4 Financials 14.05%
5 Energy 11.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AME icon
76
Ametek
AME
$58.2B
$3.03M 0.32%
36,570
-1,069
-3% -$81.2K
HTLD icon
77
Heartland Express
HTLD
$956M
$2.99M 0.32%
155,010
-23,293
-13% -$463K
PSX icon
78
Phillips 66
PSX
$81.4B
$2.99M 0.32%
31,407
CAT icon
79
Caterpillar
CAT
$387B
$2.92M 0.31%
21,568
-1,300
-6% -$173K
HUBB icon
80
Hubbell
HUBB
$27.2B
$2.77M 0.29%
23,505
-2,105
-8% -$238K
AMZN icon
81
Amazon
AMZN
$2.96T
$2.73M 0.29%
30,640
-260
-0.8% -$21.6K
BAX icon
82
Baxter International
BAX
$14.2B
$2.73M 0.29%
33,523
SPGI icon
83
S&P Global
SPGI
$120B
$2.67M 0.28%
12,700
VGT icon
84
Vanguard Information Technology ETF
VGT
$149B
$2.44M 0.26%
97,272
+7,720
+9% +$179K
GILD icon
85
Gilead Sciences
GILD
$165B
$2.41M 0.26%
37,121
-2,934
-7% -$195K
BNY
86
Bank of New York Mellon
BNY
$107B
$2.17M 0.23%
43,035
-1,647
-4% -$84.9K
BX icon
87
Blackstone
BX
$110B
$2.04M 0.22%
58,485
+13,615
+30% +$454K
BAC icon
88
Bank of America
BAC
$442B
$2.04M 0.22%
73,757
-6,995
-9% -$198K
EW icon
89
Edwards Lifesciences
EW
$51.7B
$2.03M 0.21%
31,800
XLRN
90
DELISTED
Acceleron Pharma
XLRN
$2M 0.21%
42,964
BKU icon
91
Bankunited
BKU
$3.36B
$1.98M 0.21%
59,240
-150
-0.3% -$5.17K
IAT icon
92
iShares US Regional Banks ETF
IAT
$681M
$1.97M 0.21%
45,262
-5,499
-11% -$248K
KMB icon
93
Kimberly-Clark
KMB
$36.5B
$1.93M 0.2%
15,561
+101
+0.7% +$11.7K
DVN icon
94
Devon Energy
DVN
$47.3B
$1.84M 0.19%
58,199
MOG.A icon
95
Moog Inc Class A
MOG.A
$12.8B
$1.76M 0.19%
20,300
-200
-1% -$17.4K
TXN icon
96
Texas Instruments
TXN
$261B
$1.74M 0.18%
16,360
-1,615
-9% -$167K
DUK icon
97
Duke Energy
DUK
$97.3B
$1.73M 0.18%
19,158
-154
-0.8% -$13.6K
MDT icon
98
Medtronic
MDT
$112B
$1.71M 0.18%
18,805
+36
+0.2% +$3.22K
WY icon
99
Weyerhaeuser
WY
$18.4B
$1.71M 0.18%
64,980
-5,433
-8% -$137K
GE icon
100
GE Aerospace
GE
$384B
$1.68M 0.18%
33,719
-7,527
-18% -$354K

Similar funds

Neville Rodie & Shaw's Q1 2019 Portfolio in Review

As of Q1 2019, Neville Rodie & Shaw held 256 positions worth $944M, up 14% from $824M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Neville Rodie & Shaw's Q1 2019 filing shows 19 new, 59 increased, 92 reduced and 3 closed positions. Its largest new stake was Marathon Oil Corporation: 30,176 shares worth $505K. The largest sale was JPMorgan Chase, an estimated $2.28M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 20% a quarter earlier, followed by Industrials and Technology.

  • Neville Rodie & Shaw's largest Q1 2019 buy was Marathon Oil Corporation: 30,176 shares worth $505K.
  • Neville Rodie & Shaw added most to UnitedHealth in Q1 2019, an estimated $5.03M increase.
  • Neville Rodie & Shaw's biggest Q1 2019 reduction was JPMorgan Chase, cutting an estimated $2.28M.
  • Neville Rodie & Shaw fully exited Shire pic in Q1 2019, selling an estimated $806K.
  • Neville Rodie & Shaw's ten largest holdings make up 30% of its $944M portfolio in Q1 2019.
  • Neville Rodie & Shaw opened 19 new positions and closed 3 in Q1 2019.
  • Neville Rodie & Shaw's portfolio value rose 14% quarter-over-quarter to $944M.

Based on Neville Rodie & Shaw's 13F filing for Q1 2019, filed 8 Apr 2019.